SCHEMBL21392839

SCHEMBL21392839

C=CC(=O)NC(c1ccccc1)c1ccco1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
CYP2C19 P33261 2/20 0.44
KMT2A Q03164 3/20 0.41
POLB P06746 2/20 0.41
PKM P14618 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TGM2 P21980 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN7 P35236 1/20 0.41
BLM P54132 1/20 0.41
ESR2 Q92731 1/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
GLA P06280 3/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 2/20 0.40
MAPK1 P28482 2/20 0.40
RECQL P46063 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL345815 0.84 TGM2 (0.52) ALDH1A1CYP2C19KMT2AL3MBTL1TGM2
SCHEMBL30123702 0.80 ALDH1A1 (0.50) ALDH1A1CYP2C19KMT2APOLBPKM
SCHEMBL21392918 0.79 KMT2A (0.48) ALDH1A1KMT2APOLBPKML3MBTL1
SCHEMBL17320255 0.77 TGM2 (0.52) ALDH1A1CYP2C19TGM2PTPN1LMNA
SCHEMBL16695022 0.75 ALDH1A1 (0.52) ALDH1A1CYP2C19KMT2AL3MBTL1TGM2
SCHEMBL3903507 0.73 CYP2C19 (0.68) ALDH1A1CYP2C19TGM2TSHRTDP1
SCHEMBL701472 0.72 TGM2 (0.50) ALDH1A1CYP2C19TGM2LMNAHPGD
SCHEMBL30788252 0.72 TGM2 (0.53) CYP2C19KMT2ATGM2LMNAHTT
SCHEMBL23898774 0.71 TGM2 (0.46) ALDH1A1CYP2C19TGM2LMNAHPGD
SCHEMBL7745702 0.70 CYP2C19 (0.49) ALDH1A1CYP2C19TGM2LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 ALDH1A1 4188/4885CYP2C19 4717/4885KMT2A 3168/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 ALDH1A1 4188/4885CYP2C19 4717/4885KMT2A 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.